Title: A Retrospective Study on the Delivery Outcome among the Term Pregnant Women

Authors: Dr Kamrun Nahar, Dr Md. Jahangir Alam, Dr Parul Akhte

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i7.77

Abstract

Background: Now a day’s pharmaceutical or non-pharmaceutical method are use for labor induction. For labor induction oxytocin and prostaglandins are used mostly labor induction. Recently use of misoprostol in term pregnancy is exceptionally helpful for the better result amid conveyance.

Objective: The reason for the present investigation was to see the conveyance result among the term pregnant ladies.

Methodology: This accomplice think about was completed in the Department of Obstetrics and Gynecology at Proactive medical college and hospital, Narayanganj during the period from 1st February 2016 30th January 2018. Primi or second gravida patients with the gestational age between 38 weeks to 42 weeks in singleton pregnancy with cephalic introduction and not in labor who desired conveyance purposes amid the examination time frame at any age were chosen as study populace. After appropriate choice of the cases, acceptance of work (IOL) was finished by applying Tab Misoprostol 50mcg in the back vaginal fornix. Motivation behind enlistment of work was fruitful when vaginal conveyance happened with no untoward reactions and with no careful impedance.

Result: Out of 63 pregnant ladies 23 (40%) patients had negative Bishops' score with 3-5 and 40 (60%) patients had positive Bishops' score with 6-10. This table demonstrates that 40 patients had positive pre-acceptance cervical score, among them 80% had conveyed vaginally and 20% had experienced LUCS. 23 patients had horrible cervix, among them 58% experienced vaginal conveyance and 42% experienced LUCS. Out of all investigation populace 60% of study populace who were primigravide had vaginal conveyance in 67% cases and cesarean segment in 33% cases and among 40% second gravida cases vaginal conveyance was 80% and cesarean conveyance was 20%.

Conclusion: In conclusion the utilization of misoprostol amid term pregnancy is essentially related with the typical conveyance.

Keywords: Pharmaceutical, Labor induction oxytocin, Prostaglandins.

References

  1. Allahyar, J. & Galan, H. "Premature Rupture of the Membranes."; also American College of Obstetrics and Gynecologists.
  2. Dutta DC. Text Book Of Obstetrics including Perinatology and Contraception: 6th edition 2005: New Central Book Agency(P) Ltd. 8/1 Chintamoni Das Lane, Calcutta 700 009(India): Induction of Labour:Page:520.
  3. Harman JH. Current Trends in Cervical Ripening and Labour Induction, 2001.
  4. Misoprostol". The American Society of Health-System Pharmacists. Archived from the original on 2015-02-21. Retrieved Feb 20, 2015
  5. Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption Kinetics of misoprpstol with oral or vaginal administration. ObstetGynecol 1997; 90: 88-92
  6. https://www.google.com/search?q=Misoprostol&rlz=1C1GGRV_enBD783BD783&source=lnms&tbm=isch&sa=X&ved=0ahUKEwie7bvl_bLbAhWFso8KHfJxDugQ_AUICigB&biw=1366&bih=613#imgrc=H2MXlcNPm9NRaM:
  7. Sanchez-Ramos L, Peterson DE, Delke I, Gaudier FL, Kaunitz AM. Labor induction with prostaglandin E1 misoprostol compared with dinoprostone vaginal insert: a randomized trial. Obstetrics & Gynecology 1998;91:401-405
  8. Glmezoglu AM, Villar J, Ngoc NTN, Piaggio G, Carroli G, Adetoro L, Abdel-Aleem H, Cheng L, Hofmeyr GJ, Lumbiganon P. WHO multicentre randomized trial of misoprostol in the management of the third stage of labour. Lancet 2001;358:689-695
  9. Wood, Alastair J. J.; Goldberg, Alisa B.; Greenberg, Mara B.; Darney, Philip D. (2001). "Misoprostol and Pregnancy". New England Journal of Medicine. 344 (1): 38–47. doi:10.1056/NEJM200101043440107. PMID 11136959
  10. Jahan S. Clinical study of the indications and outcome of induction of labour at I.P.G.M&R. Bangladesh College of Physicians and Surgeons: 1990
  11. Parry E, Parry D, Pattison N. Induction of labour for post term pregnancy: An observational study; Department of Obstetrics and Gynaecology; National Women’s Hospital, Auckland, New Zealand. Aust-NZ J Obstet Gynaecol, 1998;38:3:275
  12. Pfizer (September 2006). "Cytotec US Prescribing Information" (PDF). Archived from the original (PDF)on 2007-02-16. Retrieved 2007-03-15

Corresponding Author

Dr Kamrun Nahar

Consultant (Obstetrics and Gynaecology),

Institute of Child & Mother Health Matuail, Dhaka